Table 3 Neonatal outcomes of women in the two groups

Gestational weeks at delivery, wk

35.98 ± 1.82

35.52 ± 2.49

0.21

35.98 ± 2.18

35.44 ± 2.70

0.41

Birthweight, g

2778.75 ± 543.86

2617.40 ± 594.53

0.08

2749.82 ± 591.75

2571.61 ± 613.86

0.27

Apgar score ≤ 7 at 1 min

19(27.94%)

6(6.82%)

 < 0.01*

6(21.43%)

2(7.14%)

0.25

Apgar score ≤ 7 at 5 min

2(2.94%)

2(2.27%)

1.00

2(7.14%)

1(3.57%)

1.00

Neonatal ICU admission

45(66.18%)

46(52.27%)

0.08

18(64.29%)

14(50.00%)

0.28

Assisted ventilation

38(55.88%)

38(43.18%)

0.12

15(53.57%)

12(42.86%)

0.42

Pulmonary surfactant use

13(19.12%)

25(28.41%)

0.18

4(14.29%)

7(25.00%)

0.31

NRDS

12(17.65%)

24(27.27%)

0.16

4(14.29%)

6(21.43%)

0.73

Wet lung

26(38.24%)

13(14.77%)

 < 0.01*

11(39.29%)

5(17.86%)

0.08

Neonatal asphyxia

19(27.94%)

6(6.82%)

 < 0.01*

7(25.00%)

2(7.14%)

0.15

Neonatal infection

5(7.35%)

13(14.77%)

0.15

3(10.71%)

4(14.29%)

1.00

Antibiotic administration

17(25.00%)

26(29.55%)

0.53

6(21.43%)

8(28.57%)

0.54

Hyperbilirubinemia

32(47.06%)

28(31.82%)

0.05

12(42.86%)

7(25.00%)

0.16

Length of neonatal hospital stay, d

8.67 ± 7.43

9.24 ± 8.85

0.74

8.22 ± 8.61

10.86 ± 10.65

0.45